Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Immunogenicity and efficacy of HIVAX vaccine: results of a first-in-human study

Oct. 10, 2013

VAC-3S vaccine: first-in-human safety, dose and immunization results

Oct. 9, 2013

Bristol-Myers Squibb prepares and tests HIV attachment inhibitors

Oct. 9, 2013

Viriom reports data from international trial of HIV drug candidate

Oct. 9, 2013

AIC-292 shows potent anti-HIV-1 activity in vivo and in first-in-human studies

Oct. 4, 2013

Valneva enters into license agreement with International AIDS Vaccine Initiative

Oct. 3, 2013

First demonstration of vaccine-mediated elimination of SIV infection

Oct. 3, 2013

New HIV integrase inhibitors disclosed by Bristol-Myers Squibb

Sep. 30, 2013

First approval in Europe for Gilead Sciences' cobicistat

Sep. 26, 2013

Profectus BioSciences begins phase I trial of HIV plasmid DNA vaccine

Sep. 19, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...